Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TOVX
TOVX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TOVX News
Theriva Biologics Reports Q1 Financial Results and Milestones
May 06 2026
NASDAQ.COM
Theriva Biologics Q1 Financial Overview
May 05 2026
seekingalpha
Theriva Biologics Presents New Data at AACR Meeting
Apr 20 2026
NASDAQ.COM
Theriva Biologics Presents VCN-01 Clinical Data at AACR
Apr 17 2026
Newsfilter
Theriva Biologics Advances VCN-01 to Phase 3 Clinical Trial
Mar 25 2026
Newsfilter
Theriva Biologics Reports FY GAAP EPS of -$2.08
Mar 12 2026
seekingalpha
Small-Cap Acquisitions Drive Market Gains
Feb 19 2026
Newsfilter
Etsy Sells Depop to eBay for $1.2 Billion
Feb 19 2026
Benzinga
Theriva Biologics Receives EMA Support for Phase 3 Trial of VCN-01
Dec 29 2025
Benzinga
Theriva Receives EMA Approval for Phase 3 Trial of VCN-01 in Metastatic PDAC
Dec 29 2025
Globenewswire
Theriva Receives EMA Approval for Phase 3 Trial of VCN-01 in Metastatic PDAC
Dec 29 2025
Newsfilter
Theriva Biologics: Overview of Q3 Earnings
Nov 12 2025
Yahoo Finance
Theriva Biologics Addresses Uncommon Market Activity
Oct 24 2025
Newsfilter
Stock Market Update: Nasdaq and Dow Futures Rise on Third Day of Shutdown—Focus on Rumble, Rigetti, and Kodiak
Oct 03 2025
Benzinga
Theriva™ Biologics Announces Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at ASCO 2025 and Investigator Meeting to Review Topline Data from the VIRAGE Phase 2b Trial of VCN-01 in Metastatic Pancreatic Cancer
May 27 2025
Newsfilter
Theriva™ Biologics Reports First Quarter 2025 Operational Highlights and Financial Results
May 14 2025
Newsfilter
Show More News
